Home Investment Memo: SMCGLOBAL

Investment Memo: SMCGLOBAL

[s2If !current_user_can(access_s2member_level1)][lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

Our Rating:

Mehabe score: 6
G Factor: 7
Piotski Score: 7
The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 7 and Piotski score of 7. Site: SMCGLOBAL

Market Cap: Rs 984 cr Price: 87.0 Trading pe: 9.84x
Book-value: 60.2/share Div yield: 0.00 % Earning yield: 31.94%
Face-value: 2.00/share 52week high: 109.85 52week low: 65.00

Technical Analysis

  • Stock trades at 87.0, above its 50dma 74.39. It also trades above its 200dma 84.95. The stock remains bullish on techicals
  • The 52 week high is at 109.85 and the 52week low is at 65.00

Price Chart

P/E Chart

Sales and Margin

Strengths

– has delivered good profit growth of 23.87% CAGR over last 5 years
– has been maintaining a healthy dividend payout of 27.73%
-Debtor days have improved from 205.95 to 111.27 days.

Weakness

– has a low return on equity of 9.86% for last 3 years.
-‘s cost of borrowing seems high

Competition

– The industry trades at a mean P/E of 18.3x. SBI Cards trades at the industry’s max P/E of 99.82x. SMCGLOBAL trades at a P/E of 9.84x
– Industry’s mean G-Factor is 4.9 while the mean Piotski score is 7.0. SMCGLOBAL has a G-Factor of 7 and Piotski scoreof 7.
– Average 1 month return for industry is 8.7%. The max 1- month return was given by Muthoot Finance: a return of 24.88 %

Quarterly Results

  • Sales for period ended Mar 2021 is Rs 260.0 cr compared to Rs 199.0 cr for period ended Mar 2020, a rise of 30.7%
  • Operating Profits reported at Rs 56.0 cr for period ended Mar 2021 vis-vis 25.0 for period ended Mar 2020 .
  • Operating Margins expanded 897.6 bps for period ended Mar 2021 vis-vis Mar 2020 .
  • The EPS for Mar 2021 was Rs 2.86 compared to Rs 1.87 for previous quarter ended Dec 2020 and Rs 0.48 for Mar 2020

Profit & Loss Statement

Profit&Loss Comments

  • Company reported sales of Rs 893.0 cr for period ended Mar 2021 vis-vis sales of Rs 780.0 cr for the period ended Mar 2020, a healthy growth of 12.7%. The 3 year sales cagr stood at 11.1%.
  • Operating margins expanded to 21.0% for period ended Mar 2021 vis-vis 16.0% for period ended Mar 2020, expansion of 500.0 bps.
  • Net Profit reported at Rs 100.0 cr for period ended Mar 2021 vis-vis sales of Rs 24.0 cr for the period ended Mar 2020, rising 76.0%.
  • Company recorded a healthy Net Profit CAGR of 23.6% over the last 3 years

Balance Sheet Statement

Cash Flow Statement

Cash Flow comments

    Sales Growth

    Profit Growth Statement

    Profit Growth Statement

    Stock Price CAGR

    Return of Equity

    General Comments

    – The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 15.0% compared to 10.0% over the last 3 Years.
    – The stock has given a return of % on a 1 Year basis vis-vis a return of % over the last 3 Years.
    – The compounded sales growth on a TTM bassis is 14% vis-vis a compounded sales growth of 11% over the last 3 Years.
    – The compounded profit growth on a TTM basis is 324% vis-vis a compounded profit growth of 23% over the last 3 Years.

    Ratios

    Shareholding Pattern

    Conclusion

    – has delivered good profit growth of 23.87% CAGR over last 5 years
    – has been maintaining a healthy dividend payout of 27.73%
    -Debtor days have improved from 205.95 to 111.27 days. – has a low return on equity of 9.86% for last 3 years.
    -‘s cost of borrowing seems high

    [/s2If]
    Join Our Telegram Group